These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6527945)

  • 1. Critical considerations on a comparative study of two staging systems for multiple myeloma.
    Merlini G; Jayakar D
    Nouv Rev Fr Hematol (1978); 1984; 26(6):397-400. PubMed ID: 6527945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two staging systems for myeloma.
    Vercelli D; Cozzolino F; Di Guglielmo R
    Nouv Rev Fr Hematol (1978); 1981; 23(2):107-10. PubMed ID: 7290984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of five staging systems in 470 patients with multiple myeloma.
    Mihou D; Katodritou I; Zervas K
    Haematologica; 2006 Aug; 91(8):1149-50. PubMed ID: 16885059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of stratification systems in multiple myeloma. II. Clinical staging systems.
    Scudla V; Indrák K
    Neoplasma; 1985; 32(4):481-93. PubMed ID: 4047259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-image cytometry and clinical staging systems in multiple myeloma.
    Kropff M; Leo E; Steinfurth G; Esselborn H; Adler CP; Böcking A
    Anticancer Res; 1994; 14(5B):2183-8. PubMed ID: 7840520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
    Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of stratification systems in multiple myeloma. I. Risk categories (good and poor risk).
    Scudla V; Indrák K
    Neoplasma; 1985; 32(4):469-79. PubMed ID: 4047258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
    Rajkumar SV; Buadi F
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reproducibility of a mathematical model for calculating survival in multiple myeloma].
    Pasqualetti P; Casale R; Colantonio D
    Medicina (Firenze); 1989; 9(2):182-4. PubMed ID: 2811644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma].
    Pasqualetti P; Casale R; Collacciani A; Colantonio D
    Medicina (Firenze); 1989; 9(3):280-2. PubMed ID: 2615598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of skeletal lesions in multiple myeloma].
    Bettini R; Anzani P; Quadrelli CM; Mammano S; Rapazzini P; Marrapodi E; Sessa V
    Recenti Prog Med; 1989 Jun; 80(6):300-3. PubMed ID: 2672192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.